Iyengar, Neil M. http://orcid.org/0000-0002-9773-5235
Zhou, Xi Kathy http://orcid.org/0000-0002-8942-439X
Mendieta, Hillary
El-Hely, Omar
Giri, Dilip D.
Winston, Lisle
Falcone, Domenick J.
Wang, Hanhan
Meng, Lingsong http://orcid.org/0000-0003-4456-1902
Ha, Taehoon http://orcid.org/0000-0002-4533-1140
Pollak, Michael
Morrow, Monica
Dannenberg, Andrew J. http://orcid.org/0000-0002-1901-6497
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R01CA215797-01, U54 CA210184-01, 1R01CA215797-01, 1R01CA215797-01, 1R01CA215797-01, 1R01CA215797-01)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Breast Cancer Research Foundation
Botwinick-Wolfensohn Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 19 July 2020
Accepted: 13 January 2021
First Online: 1 March 2021
Competing interests
: Dr. Iyengar receives consulting fees from Novartis and Seattle Genetics. Dr. Morrow receives consulting fees from Genomic Health. The remaining authors declare no competing interests.